Yabao Pharmaceutical Group Co., Ltd (SHA:600351)
China · Delayed Price · Currency is CNY 6.20
+0.15 (2.48%)
Jul 3, 2026, 3:00 PM CST
SHA:600351 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,290 | 4,491 | 4,385 | 5,215 | 4,528 | 6,992 | |
Market Cap Growth | -1.93% | 2.42% | -15.93% | 15.19% | -35.24% | 82.33% |
Enterprise Value | 3,402 | 3,899 | 3,952 | 4,911 | 4,520 | 7,195 |
Last Close Price | 6.20 | 6.15 | 5.50 | 6.08 | 5.15 | 7.85 |
PE Ratio | 13.51 | 14.03 | 18.07 | 26.13 | 43.26 | 37.37 |
Forward PE | - | 15.89 | 15.89 | 15.89 | 15.89 | 15.89 |
PS Ratio | 1.95 | 2.01 | 1.63 | 1.79 | 1.67 | 2.53 |
PB Ratio | 1.54 | 1.59 | 1.52 | 1.74 | 1.51 | 2.36 |
P/TBV Ratio | 1.59 | 1.65 | 1.61 | 1.87 | 1.62 | 2.59 |
P/FCF Ratio | 7.49 | 8.56 | 10.03 | 13.11 | 11.37 | 20.42 |
P/OCF Ratio | 6.97 | 7.83 | 9.30 | 10.48 | 9.83 | 15.98 |
PEG Ratio | - | 2.55 | 2.55 | 2.55 | 2.55 | 2.55 |
EV/Sales Ratio | 1.55 | 1.74 | 1.47 | 1.69 | 1.66 | 2.60 |
EV/EBITDA Ratio | 7.51 | 8.77 | 9.56 | 10.98 | 13.37 | 19.77 |
EV/EBIT Ratio | 10.75 | 12.55 | 14.26 | 16.85 | 25.38 | 36.59 |
EV/FCF Ratio | 5.94 | 7.43 | 9.04 | 12.35 | 11.35 | 21.01 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.03 | 0.07 | 0.15 | 0.18 |
Debt / EBITDA Ratio | 0.08 | 0.08 | 0.23 | 0.46 | 1.29 | 1.47 |
Debt / FCF Ratio | 0.06 | 0.07 | 0.22 | 0.53 | 1.11 | 1.57 |
Net Debt / Equity Ratio | -0.30 | -0.28 | -0.17 | -0.14 | -0.07 | 0.02 |
Net Debt / EBITDA Ratio | -1.85 | -1.76 | -1.17 | -0.91 | -0.67 | 0.17 |
Net Debt / FCF Ratio | -1.45 | -1.49 | -1.10 | -1.03 | -0.57 | 0.18 |
Asset Turnover | 0.64 | 0.66 | 0.73 | 0.73 | 0.66 | 0.68 |
Inventory Turnover | 3.24 | 3.00 | 3.10 | 2.80 | 2.51 | 2.15 |
Quick Ratio | 3.05 | 3.14 | 1.83 | 1.60 | 1.40 | 1.23 |
Current Ratio | 3.92 | 4.10 | 2.68 | 2.23 | 1.88 | 1.79 |
Return on Equity (ROE) | 10.49% | 10.49% | 7.61% | 6.00% | 3.50% | 6.36% |
Return on Assets (ROA) | 5.78% | 5.69% | 4.68% | 4.56% | 2.71% | 3.04% |
Return on Invested Capital (ROIC) | 12.82% | 11.18% | 8.51% | 8.93% | 5.11% | 5.84% |
Return on Capital Employed (ROCE) | 11.00% | 10.70% | 9.40% | 9.50% | 5.80% | 6.40% |
Earnings Yield | 7.44% | 7.13% | 5.54% | 3.83% | 2.31% | 2.68% |
FCF Yield | 13.36% | 11.69% | 9.97% | 7.63% | 8.80% | 4.90% |
Dividend Yield | 4.84% | 5.69% | 5.46% | 2.47% | 0.97% | 1.02% |
Payout Ratio | 109.47% | 66.21% | 46.79% | 25.69% | 77.98% | 32.29% |
Buyback Yield / Dilution | 2.72% | 3.29% | 5.25% | 0.89% | -0.02% | 0.04% |
Total Shareholder Return | 7.68% | 8.98% | 10.71% | 3.36% | 0.95% | 1.06% |